These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9267681)

  • 1. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
    Yu Z; Hwang SS; Gupta SK
    Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers.
    Pade V; Aluri J; Manning L; Stavchansky S
    Biopharm Drug Dispos; 1995 Jul; 16(5):381-91. PubMed ID: 8527687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1994 May; 44(5):679-82. PubMed ID: 8024648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men.
    Yu Z; Gupta SK; Hwang SS; Kipnes MS; Mooradian AD; Snyder PJ; Atkinson LE
    J Clin Pharmacol; 1997 Dec; 37(12):1139-45. PubMed ID: 9506009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simulation of bioequivalence study on the base of dissolution curves].
    Grezál G; Vereczkey L
    Acta Pharm Hung; 2012; 82(2):55-9. PubMed ID: 22870777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal testosterone administration in hypogonadal men: comparison of pharmacokinetics at different sites of application and at the first and fifth days of application.
    Yu Z; Gupta SK; Hwang SS; Cook DM; Duckett MJ; Atkinson LE
    J Clin Pharmacol; 1997 Dec; 37(12):1129-38. PubMed ID: 9506008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product.
    Hwang SS; Gorsline J; Louie J; Dye D; Guinta D; Hamel L
    J Clin Pharmacol; 1995 Mar; 35(3):259-67. PubMed ID: 7608314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated model for determining causes of poor oral drug absorption.
    Yu LX
    Pharm Res; 1999 Dec; 16(12):1883-7. PubMed ID: 10644078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.
    Plusquellec Y; Campistron G; Staveris S; Barre J; Jung L; Tillement JP; Houin G
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):225-39. PubMed ID: 3668801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of drug absorption rate in time-variant disposition by direct deconvolution using beta clearance correction and end-constrained non-parametric regression.
    Neelakantan S; Veng-Pedersen P
    Biopharm Drug Dispos; 2005 Nov; 26(8):353-70. PubMed ID: 16088968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide.
    Malm-Erjefält M; Ekblom M; Vouis J; Zdravkovic M; Lennernäs H
    Mol Pharm; 2015 Nov; 12(11):4166-73. PubMed ID: 26426736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a level A in vitro-in vivo correlation for extended release dosage forms of quetiapine fumarate.
    Gonçalves de Lima L; Rossi de Campos D
    Drug Res (Stuttg); 2016 May; 66(5):225-9. PubMed ID: 26697891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.
    Wagner JG; Ganes DA; Midha KK; Gonzalez-Younes I; Sackellares JC; Olson LD; Affrime MB; Patrick JE
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):413-55. PubMed ID: 1920088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power analyses of moment analysis parameter in bioequivalence tests.
    Kaniwa N; Ogata H; Aoyagi N; Takeda Y; Uchiyama M
    J Pharm Sci; 1989 Dec; 78(12):1020-4. PubMed ID: 2614692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of controlled-release products.
    Hwang SS; Bayne W; Theeuwes F
    J Pharm Sci; 1993 Nov; 82(11):1145-50. PubMed ID: 8289130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Finite Absorption Time (F.A.T.) Concept in the Assessment of Bioequivalence.
    Tsekouras AA; Macheras P
    Pharm Res; 2024 Jul; 41(7):1413-1425. PubMed ID: 38898304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man.
    Bates TR; Pieniaszek HJ; Sequeira JA; Rasmussen JE
    Arch Dermatol; 1977 Mar; 113(3):302-6. PubMed ID: 843096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies.
    Yu Z; Schwartz JB; Sugita ET; Foehl HC
    Biopharm Drug Dispos; 1996 Aug; 17(6):521-40. PubMed ID: 8866043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.